Cancer Vaccine Type
Creative Biolabs offers a diverse portfolio of cancer vaccine types, leveraging cutting-edge technology to provide tailor-made solutions to researchers around the world. Our personalized neoantigen cancer vaccines use patient-specific tumor mutations to design highly targeted vaccines that minimize autoimmune risks while maximizing immunogenicity. For tumor cell vaccines, we have developed self/allogeneic platforms to enhance immunogenicity through cytokine modification or co-stimulatory molecule expression. Dendritic cell (DC) vaccines leverage the power of professional antigen-presenting cells, using tumor antigen pulses to trigger a powerful T-cell response. Our antigen vaccine capticons, proteins and multi-epitopes are designed to target both defined (e.g., hERT, p16INK4a) and undefined tumor antigens to gain broad applicability.
Antigen Vaccine Development Services: Offers peptide, protein, and polyepitope vaccines targeting tumor-specific antigens like hTERT and p16INK4a.
Tumor Cell Vaccine Development Services: Develops autologous/allogeneic tumor cell vaccines with cytokine modification for enhanced immunogenicity.
Dendritic Cell Vaccine Development Services: Utilizes dendritic cells pulsed with tumor antigens to induce potent T-cell responses.
Antibody-Immunostimulant Conjugate Development Services: Preclinical expertise in generating conjugates that deliver immunostimulants to specific targets, enhancing anti-tumor immune responses.
Anti-Idiotype Vaccine Development Service: Employs antibody-based mimicry to simulate tumor antigens and evoke comprehensive immune responses.
DNA based Cancer Vaccine Development Services: Provides non-replicating DNA vaccines for transient antigen expression and adaptive immunity.
mRNA based Cancer Vaccine Development Service: Delivers mRNA vaccines for rapid antigen production without genomic integration risks.
Vector based Vaccine Development Services: Uses viral/bacterial vectors (e.g., adenovirus, listeria) for efficient antigen delivery and immune activation.
Fully Synthetic Carbohydrate based Cancer Vaccine Development Services: Targets tumor-associated glycans through synthetic glycoconjugates for precise immune targeting.
Accelerate Your Research
Whether you need personalized neoantigen design, advanced vector systems, or synthetic carbohydrate constructs, Creative Biolabs has the expertise to drive your cancer vaccine project forward. Our team of scientists offers end-to-end support, from antigen discovery to GMP production, ensuring high-quality, scalable solutions. Don’t miss the opportunity to collaborate with a leader in immunotherapy innovation. Contact us via email or visit our website to discuss your unique needs and unlock the potential of next-generation cancer vaccines
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
